AI

Asif Ismail Tak

Active Director Director DIN 02606300
DIN 02606300 First appointment Apr 2005 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Apr 2005
Shareholding value •••• Premium profile

About Asif Ismail Tak

Data last updated:

Asif Ismail Tak is a Director at Biozeal Lifesciences Private Limited (since 2010), Director at Auffullen Healthcare Private Limited (since 2017) and Director at Sonav Projects And Estates Private Limited (since 2005), and holds 1 more current directorship. The companies operate in Pharma, Real Estate and Infrastructure and Utilities. The 3 current companies with reported revenue have a combined latest revenue of ₹1.54 Cr; the largest is Biozeal Lifesciences Private Limited at ₹1.37 Cr (FY 2025). Earlier, Asif Ismail Tak was a Designated Partner at Trienity Prime Property Projects Llp (2012–2015).

DIN 02606300
Primary Designation Director
Industry Pharma
First Appointment 12 Apr 2005
Oldest Company Age 34 yrs
Largest company Biozeal Lifesciences Private Limited · ₹1.37 Cr (FY 2025)
Combined revenue ₹1.54 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Biozeal Lifesciences Private Limited U24239MH2010PTC199145
Director21 Jan 20102010₹1.37 Cr (FY 2025)Active
Auffullen Healthcare Private Limited U24290MH2017PTC294627
Director26 Apr 20172017₹16.7 Lakh (FY 2025)Active
Director12 Apr 20051992₹10,250 (FY 2024)Active
Designated Partner06 Oct 20212021Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner24 Dec 20122012₹4.9 Lakh (FY 2023)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Silverspans Infra Llp
Biozeal Lifesciences Private Limited
Auffullen Healthcare Private Limited
Sonav Projects And Estates Private Limited
Premium access

Shareholding and investment profile for Asif Ismail Tak

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Asif Ismail Tak

Asif Ismail Tak currently holds 4 directorships: Biozeal Lifesciences Private Limited (Director, since 21 Jan 2010, revenue ₹1.37 Cr (FY 2025)); Auffullen Healthcare Private Limited (Director, since 26 Apr 2017, revenue ₹16.7 Lakh (FY 2025)); Sonav Projects And Estates Private Limited (Director, since 12 Apr 2005, revenue ₹10,250 (FY 2024)); Silverspans Infra Llp (Designated Partner, since 06 Oct 2021).

Asif Ismail Tak was first appointed on 12 Apr 2005 as Director at Sonav Projects And Estates Private Limited. The most recent appointment on record is 06 Oct 2021 at Silverspans Infra Llp.

The 3 current companies of Asif Ismail Tak that report revenue have a combined latest revenue of ₹1.54 Cr: Biozeal Lifesciences Private Limited ₹1.37 Cr (FY 2025); Auffullen Healthcare Private Limited ₹16.7 Lakh (FY 2025); Sonav Projects And Estates Private Limited ₹10,250 (FY 2024).

Asif Ismail Tak held 1 earlier board appointment: Trienity Prime Property Projects Llp (Designated Partner, 24 Dec 2012 to 01 Apr 2015).

The current boards of Asif Ismail Tak's companies include Pinkesh Jagdish Solanki (Biozeal Lifesciences Private Limited), Nasim Bano Asif Tak (Sonav Projects And Estates Private Limited), Ashwin Ranubhai Shah (Silverspans Infra Llp), Deep Ashwin Shah (Silverspans Infra Llp).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available